NCT05740085

Brief Summary

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Rheumatoid arthritis patients are at increased risk for developing osteoporosis. It is crucial to identify whether rheumatoid arthritis patients know and know about this disease. This study investigates awareness and knowledge of osteoporosis in rheumatoid arthritis patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 22, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 30, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

3 months

First QC Date

December 27, 2022

Last Update Submit

February 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Level of knowledge in osteoporosis

    Level of knowledge in osteoporosis will be assessed with revised osteoporosis knowledge test (OKT). The Revised OKT (2012) is a comprehensive instrument reflecting current research and assesses osteoporosis knowledge of adults. Responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect. In a U.S. sample of adults, the measure demonstrated internal consistency, very good stability, and content validity. Point-biserial correlations supported the measure's validity.

    1 day

Study Arms (1)

Rheumatoid Arthritis Patients

Patients that are diagnosed with rheumatoid arthritis

Other: Patient information form

Interventions

Patients will be asked to fill out a patient information form and an osteoporosis awareness form

Rheumatoid Arthritis Patients

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 18 to 90 years with a diagnosis of rheumatoid arthritis who gave consent to participate in the study.

You may qualify if:

  • Clinical diagnosis of rheumatoid arthritis
  • Must be between the ages of 18 and 90
  • Must give consent to participate in the study

You may not qualify if:

  • Not giving consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Üsküdar State Hospital

Istanbul, Üsküdar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

OsteoporosisArthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesArthritisJoint DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Mustafa H Temel, M.D.

    Uskudar State Hospital

    STUDY CHAIR

Central Study Contacts

Mustafa H Temel, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 27, 2022

First Posted

February 22, 2023

Study Start

April 30, 2023

Primary Completion

July 30, 2023

Study Completion

August 30, 2023

Last Updated

February 22, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations